首页> 外国专利> PREDICTION OF HEPATOCELLULAR CARCINOMA ONSET AFTER CLEARANCE OF HEPATITIS C VIRUS

PREDICTION OF HEPATOCELLULAR CARCINOMA ONSET AFTER CLEARANCE OF HEPATITIS C VIRUS

机译:清除丙型肝炎病毒后肝细胞癌的发作预测

摘要

The present invention addresses the problem of how to provide a predictive marker useful for carcinogenesis surveillance after hepatitis C virus eradication. Provided is a predictive marker composed of a single nucleotide polymorphism specified by rs17047200. In the present invention, the single nucleotide polymorphism is detected in nucleic acid samples collected from subjects, thereby to examine the risk of developing hepatocellular carcinoma after of hepatitis C virus eradication.
机译:本发明解决了在丙型肝炎病毒根除后如何提供可用于癌变监测的预测标记的问题。提供了由rs17047200指定的单核苷酸多态性组成的预测标记。在本发明中,在从受试者收集的核酸样品中检测到单核苷酸多态性,从而检查了在消灭丙型肝炎病毒后发生肝细胞癌的风险。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号